Skip to content
Screener

Praxis Precision Medicines, Inc. PRAX Business Segments — Other income, net

Similar metrics at other companies

Kosmos Energy logo
KOSGhana — Other income, net
$169K-32.9%
Redwood Trust logo
RWTAspire — Other income, net
$550K+1,046%
Redwood Trust logo
RWTCoreVest — Other income, net
-$182K-125%
Redwood Trust logo
RWTSequoia — Other income, net
$0
Kosmos Energy logo
KOSEquatorial Guinea — Other income, net
$0
Kosmos Energy logo
KOSMauritania/Senegal — Other income, net
$0

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$8.9B+770%
Enterprise value$8.43B+873%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×
Current ratio15.7×+9.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:32 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001689548-26-000083
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Elsunersen8,1411,31711,3382,078
Other early stage assets5,4711,4178,7132,522
Personnel-related expenses18,94311,91336,67324,943
Stock-based compensation expense11,3097,77028,42116,556
Depreciation expense33467293
Other segment expenses(a)12,8516,75324,94015,129
Other income, net13,1844,94026,48310,372
Consolidated net loss$(83,720)$(71,127)$(176,281)$(140,423)

Item 1. Financial Statements (Unaudited)

FAQ

What is Praxis Precision Medicines, Inc.'s business segments — other income, net?
Praxis Precision Medicines, Inc. (PRAX) reported business segments — other income, net of $13.18M in Q2 2026.
How has Praxis Precision Medicines, Inc.'s business segments — other income, net changed year-over-year?
Praxis Precision Medicines, Inc.'s business segments — other income, net increased by 166.9% year-over-year, from $4.94M to $13.18M.
What does business segments — other income, net mean?
This metric reflects non-operating income and expenses, such as interest income, foreign exchange gains or losses, and other miscellaneous financial items. It represents the net financial return on the company's cash and investment balances. It is distinct from the core clinical development activities of the business.

Ask your AI about Praxis Precision Medicines, Inc.'s business segments — other income, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude